Literature DB >> 31104078

Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure.

Hiroki Matsumoto1,2, Takatoshi Kasai3,4,5, Akihiro Sato1,2, Sayaki Ishiwata1,2, Shoichiro Yatsu1, Jun Shitara1, Azusa Murata1, Takao Kato1, Shoko Suda1, Yuya Matsue1,2, Masaru Hiki1, Atsutoshi Takagi1,6, Hiroyuki Daida1.   

Abstract

The C-reactive protein (CRP) levels obtained at hospital admission are associated with the prognosis of several cardiovascular diseases, including acute coronary syndrome. Although the admission CRP level is associated with in-hospital mortality in patients with acute decompensated heart failure (ADHF), there are limited data on the association between the admission CRP level and long-term mortality in patients with ADHF. This study included consecutive ADHF patients admitted to our institution from 2007 to 2011. Eligible patients were divided into four groups based on quartiles of admission CRP levels. The association between the admission CRP level and long-term mortality was assessed by multivariable Cox proportional analysis, including other independent variables with p values < 0.1 in the univariable analyses. Overall, 527 eligible patients were examined. There were 142 deaths (27%) during a median follow-up period of 2.0 years. In the multivariable analysis, the hazard ratio (HR) significantly increased with admission CRP levels in a dose-dependent manner for mortality (p for trend = 0.034). Multivariable analysis also showed a significant association between the admission CRP level, when treated as a natural logarithm-transformed continuous variable, and increased mortality (HR 1.16, p = 0.030). In patients with ADHF, the admission CRP level was associated with an increased risk of long-term mortality.

Entities:  

Keywords:  Biomarker; CRP; Heart failure; Mortality

Mesh:

Substances:

Year:  2019        PMID: 31104078     DOI: 10.1007/s00380-019-01435-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  53 in total

1.  Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation.

Authors:  Y Sato; Y Takatsu; K Kataoka; T Yamada; R Taniguchi; S Sasayama; A Matsumori
Journal:  Clin Cardiol       Date:  1999-12       Impact factor: 2.882

2.  TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation.

Authors:  Deborah E Sullivan; MaryBeth Ferris; Hong Nguyen; Elizabeth Abboud; Arnold R Brody
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

3.  C-reactive protein level on admission and time to and cause of death in patients hospitalized for acute heart failure.

Authors:  Yuichiro Minami; Katsuya Kajimoto; Naoki Sato; Nobuhisa Hagiwara; Teruo Takano
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2017-04-01

4.  C-reactive protein in heart failure: prognostic value and the effect of valsartan.

Authors:  Inder S Anand; Roberto Latini; Viorel G Florea; Michael A Kuskowski; Thomas Rector; Serge Masson; Stefano Signorini; Paolo Mocarelli; Allen Hester; Robert Glazer; Jay N Cohn
Journal:  Circulation       Date:  2005-08-29       Impact factor: 29.690

5.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

6.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

Authors:  T Yokoyama; L Vaca; R D Rossen; W Durante; P Hazarika; D L Mann
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte death.

Authors:  Tadashi Yoshida; Ingeborg Friehs; Srinivas Mummidi; Pedro J del Nido; Solange Addulnour-Nakhoul; Patrice Delafontaine; Anthony J Valente; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2014-08-07       Impact factor: 5.000

8.  Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

9.  Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes.

Authors:  C M Thaik; A Calderone; N Takahashi; W S Colucci
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure.

Authors:  Jonathan D Windram; Puan H Loh; Alan S Rigby; Ian Hanning; Andrew L Clark; John G F Cleland
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

View more
  6 in total

1.  Cardiopulmonary haemodynamics after sieve-shaped atrial septal defect repair: a multicenter study.

Authors:  Xianzhi Wang; Cunfu Mu; Wenlin Zhang; Chunzhu Xue; Xi Yong; Kai Chen; Dianyuan Li
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Short-Term Prognostic Efficacy of mGPS and LCS in Patients With Acute Heart Failure.

Authors:  Jing Wang; Ling Xie; Ping Lyu; Feng Zhou; Hong-Li Cai; Rong-Xing Qi; Qing Zhang
Journal:  Front Cardiovasc Med       Date:  2022-07-05

3.  The Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-19.

Authors:  Mutlu Kuluöztürk; Figen Deveci; Teyfik Turgut; Önsel Öner
Journal:  Expert Rev Respir Med       Date:  2021-05-13       Impact factor: 3.772

4.  SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy.

Authors:  Tommaso Gili; Giampaolo Benelli; Elisabetta Buscarini; Ciro Canetta; Giuseppe La Piana; Guido Merli; Alessandro Scartabellati; Giovanni Viganò; Roberto Sfogliarini; Giovanni Melilli; Roberto Assandri; Daniele Cazzato; Davide Sebastiano Rossi; Susanna Usai; Guido Caldarelli; Irene Tramacere; Germano Pellegata; Giuseppe Lauria
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

5.  CT Characteristics of Coronavirus Disease 2019 Pneumonia and Its Association with C-Reactive Protein, Erythrocyte Sedimentation Rate and Gender.

Authors:  Ali Reza Eftekhari Moghadam; Zahra Fazelinejad; Roohangiz Nashibi; Mohsen Bouri Pour
Journal:  Adv Biomed Res       Date:  2022-01-31

6.  C-reactive protein levels in the early stage of COVID-19.

Authors:  L Wang
Journal:  Med Mal Infect       Date:  2020-03-31       Impact factor: 2.152

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.